Document is current
Any future updates will be listed below
-
Authors
Kalra, Sanjay https://orcid.org/0000-0003-1308-121X
Pathan, Faruque https://orcid.org/0000-0001-9163-2473
Kshanti, Ida Ayu Made https://orcid.org/0000-0002-7918-2411
Bay, Nguyen Quang https://orcid.org/0000-0003-2847-2256
Nagase, Terumasa https://orcid.org/0000-0003-2956-0071
Oliveria, Teresa
Bajpai, Shailendra
-
Funding
Funding for this research was provided by:
BD
- License Information
-
More Information
Article History
Received: 6 March 2023
Accepted: 4 August 2023
First Online: 16 September 2023
Declarations
:
: Sanjay Kalra received speaker fees from Boehringer Ingelheim, Novo Nordisk and Sanofi. Shailendra Bajpai and Teresa Oliveria are employees and stockholders of BD/Embecta (formerly BD Diabetes Care), manufacturer of a range of insulin delivery devices. Faruque Pathan, Ida Ayu Made Kshanti, Nguyen Quang Bay, and Terumasa Nagase have nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
